FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W. FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer. OncoTargets and Therapy. 2017;10:1933–1939.The authors of this paper have advised Dove Medical Press that a collaborating laboratory h...
Main Authors: | Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-05-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/retraction-fam172a-expression-in-circulating-tumor-cells-for-pred-peer-reviewed-article-OTT |
Similar Items
-
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer
by: Xu C, et al.
Published: (2017-03-01) -
Detection of FAM172A expressed in circulating tumor cells is a feasible method to predict high-risk subgroups of colorectal cancer
by: Chun-Hui Cui, et al.
Published: (2017-05-01) -
FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling
by: Ying Chen, et al.
Published: (2020-02-01) -
The Effect of Protein FAM172A on Proliferation in HepG2 Cells and Investigation of the Possible Molecular Mechanism
by: Hong Zhao, et al.
Published: (2019-01-01) -
Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
by: Wang Gang, et al.
Published: (2009-11-01)